Frontier Bio specializes in engineered tissue technology, employing bioprinting and scaffold design to produce functional human tissue models for biomedical research and therapeutic applications. This technology addresses the critical shortage of donor organs and eliminates the need for traditional animal testing in drug development.
Funding
$6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional drug development and medical device testing rely heavily on animal models, which often fail to accurately replicate human physiology and disease, leading to inaccurate results and ethical concerns. The shortage of human organs for research and transplantation further hinders advancements in biomedical research and personalized medicine.
Solution
Frontier Bio engineers functional human tissue models using bioprinting and scaffold design to address the limitations of animal testing and the organ shortage. The company's biofabricated tissues, including lung, brain, and blood vessel microtissues, provide more relevant and ethical platforms for drug discovery, toxicity screening, and medical device testing. Frontier Bio's tissue-engineered blood vessels (TEBVs) offer an alternative to animal models for vascular medical device testing, while their lung microtissues, called RESPIRE™, bridge the gap between simpler in vitro models and whole animals for respiratory research. Their NeuroTraX™ and NeuroDots™ platforms recreate the complexities of the brain, including the blood-brain barrier, for neurological studies.
Target Audience
Frontier Bio serves pharmaceutical companies, medical device manufacturers, and research institutions seeking more accurate, ethical, and human-relevant models for drug development, toxicity screening, and medical device testing.
Features
- 3D bioprinting of complex microscale tissues with human cells
- RESPIRE™ lung microtissues containing bronchioles, alveolar airsacs, and vasculature
- NeuroTraX™ blood-brain-barrier chip for drug transport and neurological effect studies
- NeuroDots™ vascularized neurospheres for drug and toxicity screening
- Tissue-engineered blood vessels (TEBVs) with natural vessel geometry and pathology
- TissueMimX™ synthetic blood vessel models for pre-clinical medical device development and surgical training
- Custom tissue models available for specific research needs